Skip to main content
Clinical Trials/NCT04175119
NCT04175119CompletedNot Applicable

Tracking Information Flow in the Brain: A Unified and General Framework for Dynamic Communication in Brain Networks

Hospices Civils de Lyon1 site in 1 country157 target enrollmentStarted: November 25, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
157
Locations
1
Primary Endpoint
The composite characteristics of the brain oscillations (frequency, synchronization, and interaction between brain oscillations in and between different brain regions and networks)

Study Overview

Brief Summary

The brain is composed of a set of areas specialized in specific computations whose outputs need to be transferred to other specialized areas for cognition to emerge. To account for context-dependent behaviors, the information must be flexibly routed through the fixed anatomy of the brain. The aim of this project is to test a general framework for this flexible communication between brain areas based on nested oscillations. The general idea is that internally-driven slow oscillations (<20Hertz) either set-up or prevent the communication between brain areas. Stimulus-driven gamma oscillations (>30Hertz), nested in the slow oscillations, can then be directed to task-relevant areas of the network. This multimodal, multi-scale approach uses magnetoencephalography using a 3-Dimensional (3D) printed individual head-cast system and transcranial stimulation in experiments manipulating visual processing, attention and memory to test core predictions of this framework. The theoretical approach and the methodological development used in this basic science study will provide the basis for future fundamental and clinical research.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
20 Years to 36 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •20-36 years old
  • •Right handed
  • •Registered with the French healthcare system
  • •Motivated to participate in the study
  • •Normal or corrected vision
  • •Adequate knowledge of French to be able to follow directions and give informed consent
  • •Capacity to listen and follow study instructions
  • •Use of contraception (in sexually active women)
  • •BMI between 18.5 and 30
  • •Informed consent for participation in the study

Exclusion Criteria

  • •For All Experiments:
  • •Persons with :
  • •Sleep disorders, neurological or psychiatric illnesses or a history of such problems that could impact quality/variability of data or cooperation and retention of the subject in the study
  • •Migraines or light-sensitive epilepsy
  • •Regular use of medications that impact the central nervous system
  • •Regular use of medications, such as opioids and antidepressants, including Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants
  • •Severe hearing loss
  • •Skin conditions or allergies
  • •Chronic pain, or any other medical conditions conducive to pain sensitivity
  • •A history of stroke or recent trauma to the head
  • •A pacemaker, insulin or other pump, neurostimulator, cochlear implants or other hearing aid, metal stents, prosthesis, or implants, intracerebral clips, implantable defibrillator, cerebral shunt or ventricular catheter, other foreign metal objects in the upper part of the body
  • •Persons unable to adhere to abstinence from the use of drugs or alcohol the day or evening before experimental sessions
  • •Women who are pregnant, breastfeeding, or have given birth in the last 6 months
  • •For experiments using magnetoencephalography:
  • •Persons with
  • •claustrophobia
  • •any dental apparatus containing metal including or root canals
  • •any foreign metallic object anywhere in the body
  • •bolts, screws
  • •orthopedic devices or implants
  • •glasses (given the participant cannot use contact lenses)
  • •a head size incompatible with the use of a personalized 3D head-cast or a magnetoencephalograph
  • •Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body
  • •For experiments using Magnetic Resonance Imaging (MRI) or Functional Magnetic Resonance Imaging (fMRI) techniques:
  • •Anxious, non-cooperative, or agitated persons
  • •Claustrophobia
  • •Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body
  • •For experiments using transcranial stimulation:
  • •Persons with frequent syncope episodes (loss of consciousness) as a result of any particular sensorial stimulations

Arms & Interventions

Main study group

Experimental

All participants signed up for experiment 1, 2, or 3 complete the same protocol (1 study arm) with an intent for intra-subject correlational analyses.

Intervention: Visual attention/perception tasks in healthy participants (Device)

Outcomes

Primary Outcomes

The composite characteristics of the brain oscillations (frequency, synchronization, and interaction between brain oscillations in and between different brain regions and networks)

Time Frame: up to 17 months

The primary outcome measure is measured using fMRI bold signals (experiment 1), and brain signals obtained through electroencephalography (experiment 1, 3) and magnetoenecephalography (experiment 1, 3), depending on the sessions. The signals are then transformed during analyses and patterns in the composite characteristics are identified.

Secondary Outcomes

  • Coupling of brain oscillation characteristics in responses to the "flickering" effect(up to 17 months)
  • The coupling of behavioral responses to stimuli with physiological responses in the brain.(up to 17 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Tracking Information Flow in the Brain | Clinical Trial